Alpha Centric Advisors LLC Bio Xcel Therapeutics, Inc. Transaction History

Alpha Centric Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$17.7 - $33.24 $177,000 - $332,400	-10,000 Reduced 20.0%	40,000 $746,000
Q4 2021 Feb 25, 2022	BUY	$20.12 - $35.09 $301,800 - $526,350	15,000 Added 42.86%	50,000 $1.02 Million
Q3 2021 Mar 09, 2022	BUY	$23.84 - $32.03 $238,400 - $320,300	10,000 Added 40.0%	35,000 $1.06 Million
Q4 2020 Mar 11, 2022	BUY	$42.46 - $56.58 $212,300 - $282,900	5,000 Added 25.0%	25,000 $1.16 Million
Q3 2020 Mar 11, 2022	SELL	$37.44 - $64.63 $187,200 - $323,150	-5,000 Reduced 20.0%	20,000 $867,000
Q2 2020 Mar 11, 2022	BUY	$17.62 - $58.71 $440,500 - $1.47 Million	25,000 New	25,000 $1.33 Million

3.11M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $8.41M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.